Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Chart Review Study to Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection in the UK

NCT05452317 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT05452317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05452317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Chart Review Study to Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection in the UK
Lead sponsor
CSL Behring
Phase
Observational
Overall status
Completed
Start date
July 14, 2022
Completion date
April 4, 2023
Enrollment
52 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

antibody-mediated rejection in kidney transplant